Colon-Derived Liver Metastasis, Colorectal Carcinoma, and Hepatocellular Carcinoma Can Be Discriminated by the Ca2+-Binding Proteins S100A6 and S100A11
Open Access
- 2 December 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 3 (12) , e3767
Abstract
It is unknown, on the proteomic level, whether the protein patterns of tumors change during metastasis or whether markers are present that allow metastases to be allocated to a specific tumor entity. The latter is of clinical interest if the primary tumor is not known. In this study, tissue from colon-derived liver metastases (n = 17) were classified, laser-microdissected, and analysed by ProteinChip arrays (SELDI). The resulting spectra were compared with data for primary colorectal (CRC) and hepatocellular carcinomas (HCC) from our former studies. Of 49 signals differentially expressed in primary HCC, primary CRC, and liver metastases, two were identified by immunodepletion as S100A6 and S100A11. Both proteins were precisely localized immunohistochemically in cells. S100A6 and S100A11 can discriminate significantly between the two primary tumor entities, CRC and HCC, whereas S100A6 allows the discrimination of metastases and HCC. Both identified proteins can be used to discriminate different tumor entities. Specific markers or proteomic patterns for the metastases of different primary cancers will allow us to determine the biological characteristics of metastasis in general. It is unknown how the protein patterns of tumors change during metastasis or whether markers are present that allow metastases to be allocated to a specific tumor entity. The latter is of clinical interest if the primary tumor is not known.Keywords
This publication has 38 references indexed in Scilit:
- Microdissecting the proteomeProteomics, 2007
- Global proteomic analysis of microdissected cirrhotic nodules reveals significant biomarkers associated with clonal expansionLaboratory Investigation, 2006
- Identification of serum biomarkers for colon cancer by proteomic analysisBritish Journal of Cancer, 2006
- Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondromaProteomics, 2006
- High Throughput Proteome Screening for Biomarker DetectionMolecular & Cellular Proteomics, 2005
- Protein Profiling of Microdissected Prostate Tissue Links Growth Differentiation Factor 15 to Prostate CarcinogenesisCancer Research, 2004
- Biomarker Discovery and Identification in Laser Microdissected Head and Neck Squamous Cell Carcinoma with ProteinChip® Technology, Two-dimensional Gel Electrophoresis, Tandem Mass Spectrometry, and ImmunohistochemistryMolecular & Cellular Proteomics, 2003
- Identification of metastasis‐associated proteins by proteomic analysis and functional exploration of interleukin‐18 in metastasisProteomics, 2003
- Differential expression patterns ofS100a2, S100a4 andS100a6 during progression of human malignant melanomaInternational Journal of Cancer, 1997
- The S100 family of EF-hand calcium-binding proteins: functions and pathologyTrends in Biochemical Sciences, 1996